Antidotes for the new oral anticoagulants: Reality and expectations

被引：0
|
作者：
Gomez-Outes, Antonio [1 ]
Lecumberri, Ramon [2 ]
机构：
[1] AEMPS, Div Farmacol & Evaluac Clin, Madrid, Spain
[2] Univ Navarra Clin, Serv Hematol, Pamplona, Navarra, Spain
来源：
MEDICINA CLINICA | 2016年 / 146卷 / 11期
关键词：
ATRIAL-FIBRILLATION PATIENTS; INTRACRANIAL HEMORRHAGE; DABIGATRAN; MANAGEMENT; IDARUCIZUMAB; WARFARIN; TOLERABILITY; VOLUNTEERS; INHIBITORS; REVERSAL;
D O I：
10.1016/j.medcle.2015.11.031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：488 / 490
页数：3
相关论文
共 50 条
  • [1] Bleeding and antidotes in new oral anticoagulants
    Majeed, Ammar
    Schulman, Sam
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 191 - 202
  • [2] Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent
    Lauw, Mandy N.
    Coppens, Michiel
    Eikelboom, John W.
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (04) : 381 - 384
  • [3] Antidotes for the direct oral anticoagulants: What news?
    Galliazzo, S.
    Donadini, M. P.
    Ageno, W.
    THROMBOSIS RESEARCH, 2018, 164 : S119 - S123
  • [4] Specific antidotes for bleeding associated with direct oral anticoagulants
    Burnett, Allison
    Siegal, Deborah
    Crowther, Mark
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [5] Which antidotes are available for the novel oral anticoagulants?
    Thomas, Rebekah
    Gonzalez, Renzo
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (07): : 12 - 13
  • [6] Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk
    Ebright, Joseph
    Mousa, Shaker A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (02) : 105 - 114
  • [7] Recent Advances in the Development of Specific Antidotes for Target-Specific Oral Anticoagulants
    Mo, Yoonsun
    Yam, Felix K.
    PHARMACOTHERAPY, 2015, 35 (02): : 198 - 207
  • [8] Potential antidotes for reversal of old and new oral anticoagulants
    Suryanarayan, Deepa
    Schulman, Sam
    THROMBOSIS RESEARCH, 2014, 133 : S158 - S166
  • [9] Antidotes to non-vitamin K oral anticoagulants: necessary or not?
    Proietti, Marco
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1573 - 1576
  • [10] Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative Physician
    Giebler, Antasia
    Sniecinski, Roman
    CURRENT ANESTHESIOLOGY REPORTS, 2024, 14 (03) : 388 - 396
12345